B of A Securities Upgrades Surgery Partners to Buy, Raises Price Target to $45
Portfolio Pulse from richadhand@benzinga.com
B of A Securities analyst Kevin Fischbeck upgrades Surgery Partners (NASDAQ:SGRY) from Neutral to Buy and raises the price target from $42 to $45.
June 02, 2023 | 12:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Surgery Partners upgraded to Buy by B of A Securities, with price target raised from $42 to $45.
The upgrade from Neutral to Buy and the increase in price target from $42 to $45 by B of A Securities analyst Kevin Fischbeck indicates a positive outlook for Surgery Partners. This news is likely to have a positive short-term impact on the stock price as investors may see it as a signal to buy the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100